MD Anderson scientists have put the DNA of the extinct Tasmanian tiger back into transgenic mice to see how it would function, according to a paper published in PLoS ONE. Finding that thylacine Col2A1 enhancer directed chondrocyte-specific expression in the tiger the same way it does in mice, this is the first time that DNA from an extinct species has been used to examine function in a living organism.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.